RECAST study - Clinical Trial
What is the Purpose of this Study?
This study looks at different treatments for early breast cancer (DCIS). It has four parts:
- Screening: Doctors do tests to see if you can join.
- Treatment: You’re randomly placed in a group to get either standard medicine or a new treatment.
- Surgery Check: After 3 months, doctors decide if surgery is needed.
- Follow-Up: You’ll get check-ups for up to 5 years, and yearly follow-ups for 10 years.
Treatments may include pills, hormone therapy, or small pellets under the skin. You’ll also have tests like MRIs, mammograms, and blood samples.
Adults with DCIS (ductal carcinoma in situ) and hormone receptor (HR +) breast cancer
Who Can Participate in the Study?
Who can join this study:
- Adults with a type of early breast cancer called DCIS that is hormone receptor-positive (HR+).
- People who were already diagnosed with HR+ DCIS, even if it shows tiny signs of spreading.
- People who had a breast MRI within the last 2 months and a mammogram within the last 4 months to check the cancer.
What is Involved?
Doctors are doing a study to see if people with a type of early breast cancer called DCIS can be safely treated with medicine instead of surgery. They want to know if using drug therapy and regular breast scans can help avoid surgery while still keeping patients healthy.
Study Details
